Eagle Pharmaceuticals Inc (STU:1E6)
€ 3.14 0 (0%) Market Cap: 10.57 Mil Enterprise Value: 61.55 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 60/100

Eagle Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 09:15PM GMT
Release Date Price: €30.2
Albert Hwang;Morgan Stanley;Managing Director
Research Division

Hi. It's Albert Hwang. Thank you for being here, late I know. And I do need to read some research disclosures. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

So Scott, maybe you can introduce yourself quickly and give maybe a 5-minute overview on the company in case people are not familiar with the story, before we get started.

Scott L. Tarriff
Eagle Pharmaceuticals, Inc. - Founder, President, CEO & Director

I would love to, Albert. And once again, I just wanted to thank Morgan Stanley and everybody for inviting us here. This is really a highlight and how great is it that we're all here in person. Again, it's been really a great, great conference. I'm here with Brian Cahill, our CFO.

And the best way to describe Eagle, I believe everybody has known us over the years. The

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot